4021 — Nissan Chemical Balance Sheet
0.000.00%
- ¥707bn
- ¥702bn
- ¥251bn
- 100
- 49
- 89
- 95
Annual balance sheet for Nissan Chemical, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 32,380 | 34,658 | 29,647 | 22,738 | 27,454 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 77,663 | 84,303 | 87,827 | 93,860 | 93,470 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 159,588 | 175,279 | 189,454 | 201,968 | 210,352 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 51,837 | 53,177 | 64,653 | 77,372 | 72,424 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 265,509 | 279,687 | 298,715 | 323,458 | 330,763 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 59,744 | 65,971 | 72,161 | 86,563 | 79,218 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 66,680 | 73,775 | 80,296 | 95,987 | 97,472 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 198,829 | 205,912 | 218,419 | 227,471 | 233,291 |
| Total Liabilities & Shareholders' Equity | 265,509 | 279,687 | 298,715 | 323,458 | 330,763 |
| Total Common Shares Outstanding |